Published by Andrew Schonberg on 15th November 2016
(ShareCast News) - International speciality pharmaceutical company Midatech Pharma has selected its candidate compound MTR104 to take into a formal IND-enabling programme during 2017.
URL: http://www.digitallook.com/dl/news/story/25213704/...